Total citations by year in CrossRef

Year:	2010	2009	2008	2007	2005	2004	2003	2001	2000	Total
Citations:	2	1	2	4	1	1	1	1	2	15

Citations to this article in CrossRef (15)

Title and authors	Publication	Year
Clinical Implications of Lipid Genetics for Cardiovascular Disease Alanna Strong, Daniel J. Rader	Curr Cardio Risk Rep	2010
Nuclear receptors as drug targets for metabolic disease Ira G. Schulman	Advanced Drug Delivery Reviews	2010
Update on strategies to increase HDL quantity and function Danielle Duffy, Daniel J. Rader	Nat Rev Cardiol	2009
Protein Science Encyclopedia Jorge Plutzky	Protein Science Encyclopedia	2008
Translating molecular discoveries into new therapies for atherosclerosis Daniel J. Rader, Alan Daugherty	Nature	2008
Mechanisms of Disease: HDL metabolism as a target for novel therapies Daniel J Rader	Nat Clin Pract Cardiovasc Med	2007
Will torcetrapib be the next big thing in coronary heart disease risk reduction? James M. McKenney, John A. Hoekstra	Curr Atheroscler Rep	2007
ApoA-I induces a preferential efflux of monounsaturated phosphatidylcholine and medium chain sphingomyelin species from a cellular pool distinct from HDL3 mediated phospholipid efflux Rainer Schifferer, Gerhard Liebisch, Sascha Bandulik, Thomas Langmann, Ashraf Dada, Gerd Schmitz	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2007
Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype Jeffrey Rhyne, Seung Ho Hong, Michael Miller, Myrna Mantaring	Translational Research	2007
Gene therapy for lipoprotein disorders Uli C Broedl, Daniel J Rader	Expert Opin. Biol. Ther.	2005

« Previous 1 2 Next »